InsidersTradesSigma
Follow the 리센스메디컬 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 리센스메디컬 has published 2 reports. The latest transaction was reported on 9 June 2026 (Sale). Among the most active insiders: 한국산업은행. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
리센스메디컬 是一家在XKRX市场上市的医疗保健和制药公司。它专注于开发创新的医疗解决方案。